Technical Analysis for SNDX - Syndax Pharmaceuticals, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 19.27 | -0.10% | -0.02 |
SNDX closed down 0.1 percent on Friday, May 31, 2024, on 87 percent of normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 200 DMA Support | Bullish | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Down 4 Days in a Row | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Multiple of Ten Bearish | Other | -0.10% | |
| Outside Day | Range Expansion | -0.10% | |
| Down 3 Days in a Row | Weakness | -0.10% | |
| Oversold Stochastic | Weakness | -0.10% | |
| Spinning Top | Other | -2.28% | |
| NR7 | Range Contraction | -2.28% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | 1 day ago |
| Fell Below Previous Day's Low | 1 day ago |
| Up 2% | 1 day ago |
| Up 1% | 1 day ago |
| Down 1% | 2 days ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/16/2024
Syndax Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics in oncology. The company's lead product candidate is entinostat, an epigenetic therapy for treatment-resistant cancers, such as breast cancer and lung cancer, as well as other indications comprising solid tumors and hematological malignancies. Its Entinostat is an oral histone deacetylase inhibitor that targets cancer cell growth and resistance pathways that limit the effectiveness and durability of cancer therapies. The company has a collaborative research and development agreement with the National Cancer Institute; and Genentech. Syndax Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Waltham, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Clinical Medicine Solid Tumors Breast Cancer Antineoplastic Drugs Treatment Of Breast Cancer Lung Cancer Cancer Cell Cancer Therapies Hematological Malignancies Pyridines National Cancer Institute Benzamides Histone Deacetylase Inhibitor
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Clinical Medicine Solid Tumors Breast Cancer Antineoplastic Drugs Treatment Of Breast Cancer Lung Cancer Cancer Cell Cancer Therapies Hematological Malignancies Pyridines National Cancer Institute Benzamides Histone Deacetylase Inhibitor
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 25.34 |
| 52 Week Low | 11.23 |
| Average Volume | 967,712 |
| 200-Day Moving Average | 19.16 |
| 50-Day Moving Average | 21.60 |
| 20-Day Moving Average | 21.00 |
| 10-Day Moving Average | 20.07 |
| Average True Range | 0.89 |
| RSI (14) | 34.21 |
| ADX | 18.24 |
| +DI | 14.09 |
| -DI | 27.16 |
| Chandelier Exit (Long, 3 ATRs) | 20.56 |
| Chandelier Exit (Short, 3 ATRs) | 21.81 |
| Upper Bollinger Bands | 23.18 |
| Lower Bollinger Band | 18.82 |
| Percent B (%b) | 0.1 |
| BandWidth | 20.77 |
| MACD Line | -0.61 |
| MACD Signal Line | -0.44 |
| MACD Histogram | -0.169 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 20.22 | ||||
| Resistance 3 (R3) | 20.28 | 20.03 | 20.06 | ||
| Resistance 2 (R2) | 20.03 | 19.79 | 20.00 | 20.00 | |
| Resistance 1 (R1) | 19.65 | 19.64 | 19.53 | 19.59 | 19.95 |
| Pivot Point | 19.40 | 19.40 | 19.34 | 19.37 | 19.40 |
| Support 1 (S1) | 19.02 | 19.16 | 18.90 | 18.96 | 18.59 |
| Support 2 (S2) | 18.77 | 19.01 | 18.74 | 18.54 | |
| Support 3 (S3) | 18.39 | 18.77 | 18.48 | ||
| Support 4 (S4) | 18.33 |
